Medx Health Corp V.MDX

Some insight

[Insightful1]

Regarding Google's AI Derm Tool;

It is simply a tool, Google is in the business of selling Metadata. I you read the actual white paper;

https://www.nature.com/articles/s41591-020-0842-3.epdf?sharing_token=wuTAJEbC95l4C7v6NtxT_9RgN0jAjWel9jnR3ZoTv0OFeStHBU1iZZ82HqV-wRjkX19a-1vGH8dVvj-wIjuLX7t5r_oHnLoJjtM6MuwYTQ8jt7BtFtgd5EYmLy46_LdutTIEe3alRaP7NOHyG4_QU9VVqK6mY0F1c100RxpsaAU%3D

you will see that Google is merely colecting metadata from people who are willing to upload photos of their condition to the Goolgle tool, It is not a diagnostic tool. Google noticed lots of people were serching skin conditions (over a million hits a day)  on their search engine and are now trying to add information to that search using AI as a classifier. Absolutely useless in the real world environment, in fact it has a very poor analytic score and now you will have a tool that has people heading to their dermatolgist with what they think is a diagnosis.

Here is the problem, Google will never say it is a medical diagnosis because of the liability, people will use it as if it is a diagnosis and try to gain access to a dermatologist. It will jusy adding more pressure to an already stressed system. Google is in it to sell the data...full stop.

MedX's AI solves real world problems. The biggest issue facing teledermatology is the quality of the images being sent to the dermatologists, 42 % of images that are sent to a dermatologist for assessment are rejected.MedX certifies using its applied AI that the imagessent by their system are readable by a dermatologist. Real World functional AI.

Google with its free AI tool will put most of the Dermatology mobile pay apps out of business with this announcement. If you were a company like MetaOptima with their Diagnostis AI engine I would be quite concerned or any of the othe mobile based AI solutions with Google's announcement as Google's accuracy is better and it is free.

As for Maple they mostly do skin lesions not melanoma so to speak. They can recommend derms but they still cannot solve the bad image issue. So derms use this as a way to attract patients like in the article mentioned about fotofinder. Fotofinder is a small market system that is designed to track patients with ~50 moles on their body (molemapping) . Mole mapping uses a complete picture of your body at a moment in time when you come back and are rescanned it shows if you have any new moles on your body. It is used by derms for certain cases it is not applicable in a pharmacy setting . No one is going to go into a pharmacy strip down to thei undies and take 20 minutes to have a full body scan. This is a specific use technology.

I hope this helps.

[hopefull]

thanks for the in depth response, Mdx tech is definitely in the for front, but what we all are really searching for is evidence of industry acceptability. Mike on numerous times mentioned melanoma month thinking that it would bring attention to mdx. Hasn't happened and the month is pretty much over, I believe as investors we were quite excited to hear finally that some marketing would be

[Insightful1]

I think the issue with MedX is they have said that they are engaged in a number of large scale contracts in mutiple countries. This is the tough part as investors, these type of contracts move at a very slow pace but once you get the go ahead it is large recurring revenue base to MedX for years to come. The Netherlands is a perfect example. MedX making a big announcement about melanoma month is

[Bogeyfree1]

Does MDX have enough money, revenues, to wait for the large scale contracts to hopefully be signed not knowing when this could happen? Thank you!

[Insightful1]

I suspect with the recent financings and the fact they have been able to attract institutional capital it would suggest smart money believes they are going to hit their revenue targets. So I think they are probably on track to be revenue positive by year end. 

[Dunworkin2]

  Curious to find out what "revenue targets" you are referring to? Robert von der Porten said they don't do forward looking forecasts in his YouTube video. Revenue positive? Are you referring to them becoming cash flow positive from revenues? ( and not from further capital raises).

[melvination]

Classic hack call- positive revenue, positive revenue... By the end of the year... Another prediction!

[hopefull]

[hopefull]

I really think we have to wait till the 30th before you can make those kind of statements. As Mike has stayed in the past that this is the quarter that Brazil pio's should appear and some revenue from the Netherlands should appear. If that does not materialize on the next financials then we have to look at the quality of the statements being made by Mike and management. But I believe on the